INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
05/03/2025
Back to search
Official data from USPTO
QUANTIPLEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
QUANTIPLEX
ST13
US500000079124568Class
1, 5
Filing
79124568
Registration
4405272
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
05/04/2025
Trademark type
Word
Nice classes
1, 5
Filing date
12/12/2012
Registration date
09/24/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/01/2024
Last transaction
05/04/2025
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
Hilden, DE
Examiner
DIXON, JENNIFER
Current location
Historical data usage
Holders and representatives
Holders
QIAGEN GmbH
QIAGEN GmbH
Representatives
Victoria Friedman Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemical and biotechnological products for industrial and scientific purposesdiagnostic preparations except for human or veterinary medical purposesnonmedical reagentsenzymes and buffer solutions for scientific and medical research use for sample preparationmodification and manipulation of cells and for conducting markingseparatingisolatingpurifyingduplicating and analyzing biopolymers in the nature of nucleic acidsproteinsmacromolecules and biologically active substancesreagentsenzymes and buffer solutions for nucleic acid amplification by polymerase chain reaction (PCR) ; kits comprising chemicals for sample preparationmodification and manipulation of cells and for markingseparatingisolatingpurifyingduplicating and analyzing biopolymers in the nature of nucleic acidsproteinsmacromolecules and biologically active substancesnucleic acids of biological or biochemical sample material comprising chemicals for reagentsenzymes and buffer solutions for nucleic acid amplification by polymerase chain reaction (PCR)
Class 5
Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposesdiagnostic preparations for sample preparationmodification and manipulation of cells and for markingseparatingisolatingpurifyingduplicating and analyzing biopolymers in the nature of nucleic acidsproteinsmacromolecules and biologically active substancesreagentsenzymes and buffer solutions for nucleic acid amplification by polymerase chain reaction (PCR); chemicalbiochemical and biotechnological preparationsreagentsenzymes and buffer solutions for sample preparationmodification and manipulation of cells and for conducting markingseparatingisolatingpurifyingduplicating and analyzing biopolymers in the nature of nucleic acidsproteinsmacromolecules and biologically active substances for diagnostic medical and clinical usereagentsenzymes and buffer solutions for nucleic acid amplification by polymerase chain reaction (PCR); kits containing preparations for medical and veterinary diagnostic purposesin particular for sample preparationmodification and manipulation of cells and for markingseparatingisolatingpurifyingduplicating and analyzing biopolymers in the nature of nucleic acids from biological or biochemical sample material for nucleic acid amplification by polymerase chain reaction (PCR)
Publications
History of USPTO decisions and trademark events.
47 publications found
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
04/14/2025
INPC
INVALIDATION PROCESSED
04/14/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
02/01/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
06/01/2024
71AG
REGISTERED-SEC.71 ACCEPTED
06/01/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/28/2024
PR71
POST REGISTRATION ACTION MAILED - SEC.71
05/13/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/05/2024
ES71
TEAS SECTION 71 RECEIVED
09/05/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/30/2022
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
09/24/2022
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
08/27/2019
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
08/27/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/26/2019
ES75
TEAS SECTION 71 & 15 RECEIVED
07/31/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/18/2018
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/24/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/29/2014
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/22/2014
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/25/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/09/2014
FIMP
FINAL DISPOSITION PROCESSED
01/09/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/24/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
09/24/2013
GPNX
NOTIFICATION PROCESSED BY IB
07/22/2013
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/12/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/09/2013
PUBO
PUBLISHED FOR OPPOSITION
07/09/2013
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/19/2013
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/19/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/19/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/03/2013
ALIE
ASSIGNED TO LIE
05/31/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/16/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/11/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/10/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/10/2013
RFNP
REFUSAL PROCESSED BY IB
04/16/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/25/2013
RFRR
REFUSAL PROCESSED BY MPU
03/25/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/23/2013
CNRT
NON-FINAL ACTION WRITTEN
03/22/2013
DOCK
ASSIGNED TO EXAMINER
03/15/2013
MAFR
APPLICATION FILING RECEIPT MAILED
02/15/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/11/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/09/2013
Continuous trademark protection
Get notified about every new filing that threatens QUANTIPLEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.